日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Hetrombopag Added to Cyclosporine as the First-Line Treatment for Patients With Non-Severe Aplastic Anemia: A Phase 2 Multicenter Trial

海曲波帕联合环孢素作为非重型再生障碍性贫血患者的一线治疗:一项 II 期多中心试验

Zhang, Lele; Li, Ruonan; Liang, Qian; Li, Weiwang; Pan, Hong; Gao, Zhen; Fang, Liwei; Zhao, Jingyu; Yu, Xiao; Kuang, Zhexiang; Nie, Neng; Li, Jianping; Huang, Jinbo; Zhao, Xin; Ge, Meili; Zheng, Yizhou; Li, Jun; Zhang, Hong; Shi, Jun

Low-dose cyclophosphamide combined with standard immunosuppressive therapy improves early response rates in severe aplastic anemia

低剂量环磷酰胺联合标准免疫抑制疗法可提高重型再生障碍性贫血的早期缓解率

Pan, Hong; Gao, Zhen; Zhang, Lele; Li, Weiwang; Li, Ruonan; Zhao, Jingyu; Yu, Xiao; Kuang, Zhexiang; Nie, Neng; Li, Jianping; Li, Yuan; Li, Xingxin; Huang, Jinbo; Zhao, Xin; Zhang, Jing; Ge, Meili; Zheng, Yizhou; Fang, Liwei; Shi, Jun

The profile of clinical and laboratory features of Chinese VEXAS syndrome patients with hematological abnormalities: a single-center case series

中国VEXAS综合征伴血液学异常患者的临床和实验室特征:单中心病例系列研究

Shi, Juanli; Long, Xiaoli; Zhang, Mai; Zhang, Xiao; Cheng, Meiling; Yin, YangYang; Xiang, Geng; Zhao, Lina; Wang, Xia; Yang, Yunjiao; Pan, Junhua; Chen, Qiu; Ren, Xiang; Wang, Min; Huo, Jiali; Jia, Yujiao; Xiao, Jigang; Nie, Neng; Huang, Jinbo; Zhang, Jing; Zhao, Xin; Fang, Liwei; Peng, Guangxin; Zhang, Li; Zhang, Fengkui; Zheng, Yizhou; Shi, Jun; Ge, Meili

Very-low-dose decitabine and rhTPO for thrombocytopenia in lower-risk myelodysplastic syndrome

低危骨髓增生异常综合征患者血小板减少症的极低剂量地西他滨和重组人血小板生成素

Gao, Zhen; Yang, Fei; Pan, Hong; Zhang, Lele; Li, Weiwang; Li, Ruonan; Zhao, Jingyu; Luo, Yuechen; Yu, Xiao; Kuang, Zhexiang; Nie, Neng; Li, Jianping; Huang, Jinbo; Zhao, Xin; Ge, Meili; Zheng, Yizhou; Fang, Liwei; Shi, Jun

Targeting interleukin-2-inducible T cell kinase ameliorates immune-mediated aplastic anemia.

靶向白细胞介素-2诱导的T细胞激酶可改善免疫介导的再生障碍性贫血

Li Weiwang, Lian Yu, Zhang Lele, Li Ruonan, Liang Qian, Mao Jin, Qiu Chen, Li Haoyuan, Huang Ke, Li Qiaoli, Shen Yucan, Yang Fei, Tian Linzhu, Xiao Tingfang, Gu Shilong, Pan Hong, Gao Zhen, Zhao Jingyu, Fang Liwei, Ge Meili, Yuan Weiping, Chu Yajing, Shi Jun

Structure Optimization of Polymerase Chain Reaction Devices Under High Flow Rate: A Numerical Study

高流速下聚合酶链式反应装置的结构优化:数值研究

Zhou, Naixiang; Han, Hao; Fang, Liwei; Li, Shizhen; Lei, Li

Azacitidine in combination with HAG for newly diagnosed and relapsed/refractory AML: a prospective cohort study

阿扎胞苷联合HAG治疗新诊断和复发/难治性急性髓系白血病:一项前瞻性队列研究

Pan, Hong; Gao, Zhen; Lian, Yu; Zhao, Jingyu; Zhang, Lele; Li, Weiwang; Li, Ruonan; Liang, Qian; Xu, Jing; Li, Liyun; Yu, Xiao; Kuang, Zhexiang; Shi, Jun; Fang, Liwei

Somatic mutations and the efficacy of immunosuppressive therapy in severe/very severe aplastic anemia and transfusion-dependent nonsevere aplastic anemia

体细胞突变与重度/极重度再生障碍性贫血和输血依赖型非重度再生障碍性贫血的免疫抑制治疗疗效

Ye, Lei; Zhang, Li; Zhang, Donglei; Zhao, Xin; Li, Yuan; Xiong, Youzhen; Fang, Liwei; Ge, Meili; Shi, Jun; Zhang, Fengkui; Jing, Liping

Assessing serum thrombopoietin for enhanced diagnosis of ITP, AA, and MDS using machine learning: A retrospective cohort study.

利用机器学习评估血清血小板生成素以增强 ITP、AA 和 MDS 的诊断:一项回顾性队列研究

Zhu Guoqing, Ren Yansong, Wang Lele, Wang Shoulei, Wang Yansheng, Fan Yulong, Huang Lunhui, Xia Yonghui, Fang Liwei

Treatment-free survival to bortezomib combined with dexamethasone in patients with refractory/relapsed pure red cell aplasia: a prospective clinical study

硼替佐米联合地塞米松治疗难治性/复发性纯红细胞再生障碍性贫血患者的无治疗生存期:一项前瞻性临床研究

Zhang, Lele; Shen, Yucan; Li, Ruonan; Pan, Hong; Gao, Zhen; Li, Weiwang; Zhao, Jingyu; Liang, Qian; Fang, Liwei; Shi, Jun